MRM logo

MEDIROM Healthcare Technologies Inc. Stock Price

NasdaqCM:MRM Community·US$16.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

MRM Share Price Performance

US$2.05
-0.60 (-22.64%)
US$2.05
-0.60 (-22.64%)
Price US$2.05

MRM Community Narratives

There are no narratives available yet.

Recent MRM News & Updates

Returns On Capital At MEDIROM Healthcare Technologies (NASDAQ:MRM) Paint A Concerning Picture

Oct 02
Returns On Capital At MEDIROM Healthcare Technologies (NASDAQ:MRM) Paint A Concerning Picture

MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Held Back By Insufficient Growth Even After Shares Climb 29%

Sep 06
MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Held Back By Insufficient Growth Even After Shares Climb 29%

Is It Too Late To Consider Buying MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM)?

Jul 30
Is It Too Late To Consider Buying MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM)?

MEDIROM Healthcare Technologies' (NASDAQ:MRM) Earnings Might Be Weaker Than You Think

May 07
MEDIROM Healthcare Technologies' (NASDAQ:MRM) Earnings Might Be Weaker Than You Think

Further Upside For MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Shares Could Introduce Price Risks After 25% Bounce

Apr 17
Further Upside For MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Shares Could Introduce Price Risks After 25% Bounce

MEDIROM Healthcare Technologies Inc. Key Details

JP¥8.3b

Revenue

JP¥6.1b

Cost of Revenue

JP¥2.2b

Gross Profit

JP¥2.1b

Other Expenses

JP¥148.8m

Earnings

Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
Earnings per share (EPS)
18.83
Gross Margin
27.07%
Net Profit Margin
1.79%
Debt/Equity Ratio
190.0%

MEDIROM Healthcare Technologies Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Moderate risk with acceptable track record.

5 Risks
2 Rewards

About MRM

Founded
2000
Employees
645
CEO
Kouji Eguchi
WebsiteView website
medirom.co.jp

MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program that utilizes Lav, an on-demand health monitoring smartphone application, as well as MOTHER Bracelet for fitness and health applications; and provides preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. The company also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Japanese Market Performance

  • 7 Days: -1.8%
  • 3 Months: 10.3%
  • 1 Year: 15.3%
  • Year to Date: 13.5%
Over the last 7 days, the market has dropped 1.8%, driven by declines in the Consumer Discretionary and Financials sectors of 3.6% and 4.0%, respectively. In contrast to the last week, the market is actually up 15% over the past year. Earnings are forecast to grow by 8.2% annually. Market details ›